DMA
I have faith in the Australian legal system. In this playing field, Biota and GSK have equal competencies.
GSK thought Biota was too small, it pays the CEO more money than the royalty paid to Biota. However, in the legal arena, Biota has sufficient resources for this project.
Cheers
Add to My Watchlist
What is My Watchlist?